Timothy S. Nelson
chemical
3-V BIOSCIENCES
Burundi
Biography
Mr. Nelson served as MAP Pharmaceuticals’ President and Chief Executive Officer and as a member of its Board of Directors from April 2005 until March 2013 when the company was acquired by Allergan for $960 million. From 1998 to 2005, Mr. Nelson served as Senior Vice President of Commercial and Business Development at DURECT Corporation. From 1992 to 1998, Mr. Nelson held various senior management positions with Medtronic, including Business Director of the Neurological Division for Europe, the Middle East and Africa from 1996 to 1998 and Manager of Drug Delivery Ventures from 1992-1996. Mr. Nelson has served on other Boards of Directors, including as Chairman of the Board of Civitas, a private biopharmaceutical company focused on treating undermet medical needs in neurological indications, from December 2013 to October 2014 when the company was acquired by
Research Interest
drug elivery biopharmaceuticals medical instrumentation technology.
